Hepatitis C: all 2,356 studies

Page 24 of 24. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.

• Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis CCompletedNCT00120835Phase 1/2
• Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis CTerminatedNCT00119119Phase 3
• A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis CCompletedNCT00118768Phase 2
• A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1CompletedNCT00115908Phase 2
• The Ribavirin Pregnancy RegistryTerminatedNCT00114712
• SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis CCompletedNCT00110799Phase 2
• VISN 20: Prophylactic Treatment of Interferon-Induced Depression in Hepatitis C PatientsCompletedNCT00108563Phase 4
• Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected AdultsCompletedNCT00100581Not applicable
• A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis CCompletedNCT00097435Phase 2
• Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis CCompletedNCT00097045Phase 2
• Adult-to-Adult Living Donor Liver Transplantation StudyCompletedNCT00096733
• Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment NaiveCompletedNCT00093093Phase 3
• Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis CCompletedNCT00088504Phase 2
• A Caspase Inhibitor in Chronic Hepatitis C (HCV) PatientsCompletedNCT00088140Phase 2
• Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined TherapyCompletedNCT00086541Phase 3
• CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)CompletedNCT00084279Phase 2
• Leukapheresis for Research on HCV-Coinfected PatientsCompletedNCT00076427
• Racial Difference in HCV/Host InteractionsCompletedNCT00071916
• 12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.Status unknownNCT00069511Phase 2
• Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two DrugsCompletedNCT00062816Phase 1/2
• Hepatitis C: Grading and Staging by MRCompletedNCT00059397
• Zidovudine Levels in HIV Infected Patients Being Treated for HCVCompletedNCT00059358Phase 1/2
• Treatment of Cholestatic Pruritus With SertralineCompletedNCT00058903Phase 2
• IdB 1016 Treatment for Hepatitis C DiseaseCompletedNCT00055445Phase 1/2
• Treatment of Hepatitis C in Hemophilic Patients With HIVCompletedNCT00055341Phase 2
• Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)WithdrawnNCT00051077Phase 2
• Study of FK788 in Subjects With Chronic Hepatitis C Virus InfectionCompletedNCT00047814Phase 2
• Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or CirrhosisCompletedNCT00043303Phase 2
• Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus RibavirinCompletedNCT00040027Phase 3
• Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus RibavirinCompletedNCT00039962Phase 3
• Hepatitis C Antiviral Resistance in African-AmericansCompletedNCT00038974Phase 3
• Prevalence of Hepatitis C Virus Infection in HIV-Infected ChildrenCompletedNCT00037076
• ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus InfectionsCompletedNCT00035945Phase 2
• The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and RibavirinCompletedNCT00031343Phase 2
• Evaluating Silymarin for Chronic Hepatitis CCompletedNCT00030030Phase 2
• Gamma Interferon Therapy for Chronic Hepatitis CCompletedNCT00028275Phase 2
• Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and FibrosisWithdrawnNCT00023218Not applicable
• Effects of Ribavirin on Zidovudine or StavudineCompletedNCT00021632
• Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV CoinfectionCompletedNCT00015652Not applicable
• Herbal Treatment of Hepatitis C in Methadone Maintained PatientsCompletedNCT00010816Phase 2
• A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)CompletedNCT00008463Phase 2
• To Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C, Along With Associated Risk Behaviors, in Patients With Severe Mental Illness (SMI).CompletedNCT00007709
• Hepatitis C in Clinically Discordant Hemophilic SiblingsCompletedNCT00007371
• Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C VirusCompletedNCT00006643
• Immune Response to Hepatitis C VirusCompletedNCT00006301
• Genetics of Hepatitis C Virus InfectionCompletedNCT00005657
• Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV QuasispeciesCompletedNCT00004851
• Epidemiology, Infectivity and Natural History of Hepatitis C Virus InfectionCompletedNCT00004850
• Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIVCompletedNCT00004846
• Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis CCompletedNCT00004804Phase 3
• History of Hepatitis C in Volunteer Blood DonorsCompletedNCT00001982
• Long-Term Therapy With Ribavirin for Chronic Hepatitis CCompletedNCT00001854Phase 4
• Combination Drug Therapy for Patients With Hepatitis CCompletedNCT00001729Phase 3
• Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in JapanCompletedNCT00001712
• A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C InfectionCompletedNCT00001117
• The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV InfectionsCompletedNCT00001035Phase 1

← Hepatitis C overview